Damion Nero

Damion Nero, Head of Data Science at Takeda Pharmaceuticals, shares his expertise in applying AI and machine learning to drug development. He discusses how AI is revolutionizing clinical trials by streamlining tasks and enhancing patient engagement. Topics include the transformative potential of decentralized models and the integration of diverse data sources. Damion also highlights the ongoing challenges of trust and data integrity in healthcare, as well as the promise of future advancements in supply chain efficiency.